Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Singer

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 22, 2005
Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine SocietyHossein Gharib, R Michael Tuttle, H Jack Baskin, et al.
Nature Biotechnology|May 12, 2009
Small but tenacious: South Africa's health biotech sectorSara Al-Bader, Sarah E Frew, Insiya Essajee, et al.
Nature Biotechnology|June 10, 2008
Brazilian health biotech--fostering crosstalk between public and private sectorsRahim Rezaie, Sarah E Frew, Stephen M Sammut, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2005
Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine SocietyHossein Gharib, R Michael Tuttle, H Jack Baskin, et al.
Plos Medicine|September 14, 2006
Regenerative medicine and the developing worldHeather L Greenwood, Peter A Singer, Gregory P Downey, et al.
Plos Medicine|April 6, 2005
Nanotechnology and the developing worldFabio Salamanca-Buentello, Deepa L Persad, Erin B Court, et al.
BMC Public Health|July 2, 2010
'Relief of oppression': an organizing principle for researchers' obligations to participants in observational studies in the developing worldJames V Lavery, Sunita V S Bandewar, Joshua Kimani, et al.
Nature Biotechnology|January 11, 2012
Factors influencing agbiotech adoption and development in sub-Saharan AfricaObidimma C Ezezika, Abdallah S Daar, Kathryn Barber, et al.
Plos Medicine|June 11, 2009
In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?James V Lavery, Peter A Singer, Renee Ridzon, et al.
Plos Medicine|September 14, 2007
Grand challenges in global health: the ethical, social and cultural programPeter A Singer, Andrew D Taylor, Abdallah S Daar, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 22, 2005
Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine SocietyHossein Gharib, R Michael Tuttle, H Jack Baskin, et al.
Nature Biotechnology|May 12, 2009
Small but tenacious: South Africa's health biotech sectorSara Al-Bader, Sarah E Frew, Insiya Essajee, et al.
Nature Biotechnology|June 10, 2008
Brazilian health biotech--fostering crosstalk between public and private sectorsRahim Rezaie, Sarah E Frew, Stephen M Sammut, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2005
Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine SocietyHossein Gharib, R Michael Tuttle, H Jack Baskin, et al.
Plos Medicine|September 14, 2006
Regenerative medicine and the developing worldHeather L Greenwood, Peter A Singer, Gregory P Downey, et al.
Plos Medicine|April 6, 2005
Nanotechnology and the developing worldFabio Salamanca-Buentello, Deepa L Persad, Erin B Court, et al.
BMC Public Health|July 2, 2010
'Relief of oppression': an organizing principle for researchers' obligations to participants in observational studies in the developing worldJames V Lavery, Sunita V S Bandewar, Joshua Kimani, et al.
Nature Biotechnology|January 11, 2012
Factors influencing agbiotech adoption and development in sub-Saharan AfricaObidimma C Ezezika, Abdallah S Daar, Kathryn Barber, et al.
Plos Medicine|June 11, 2009
In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?James V Lavery, Peter A Singer, Renee Ridzon, et al.
Plos Medicine|September 14, 2007
Grand challenges in global health: the ethical, social and cultural programPeter A Singer, Andrew D Taylor, Abdallah S Daar, et al.
Pageof 16